Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Futura All Set For US FDA De Novo Application For Eroxon OTC ED Treatment

Oct 04 2022

• By David Ridley

• Source: Shutterstock

Related Content

Futura Takes Drug-Free Erectile Dysfunction Gel To Latin America

Sep 06 2021

Futura Strikes Deal To Commercialize Erectile Dysfunction Gel In Middle East

Sep 28 2021

Watch Out Viagra! UK’s Futura Set To Shake Up Global ED Market With MED3000

Jul 07 2020

Futura Pens Deal With Cooper To Launch Erectile Dysfunction Gel In Europe

May 26 2022

US OTC Switch For Cialis At Top Of To-Do List For Sanofi’s North American Consumer Health Chief

Aug 03 2022

Positive Study Results Put Futura’s OTC Erectile Dysfunction Gel On Track For 2023 US Launch

Sep 01 2022

Related Companies

Futura Medical plc

Additional Topics

US States Business Strategies Clinical Trials Commercial Companies Deals FDA Innovation Launches OTC Devices OTC Drugs Research & Development StartUps and SMEs Strategy Consumer Medical Device

More from Innovation & IP

More from Health

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.